Compare EVO & ADTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | ADTN |
|---|---|---|
| Founded | 1993 | 1985 |
| Country | Germany | United States |
| Employees | 4766 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 895.8M | 1.0B |
| IPO Year | N/A | 1996 |
| Metric | EVO | ADTN |
|---|---|---|
| Price | $2.76 | $13.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $14.67 |
| AVG Volume (30 Days) | 106.1K | ★ 1.7M |
| Earning Date | 04-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 90.83 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,083,807,000.00 |
| Revenue This Year | N/A | $11.18 |
| Revenue Next Year | $0.21 | $9.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.46 |
| 52 Week Low | $2.31 | $7.06 |
| 52 Week High | $4.80 | $13.25 |
| Indicator | EVO | ADTN |
|---|---|---|
| Relative Strength Index (RSI) | 53.62 | 71.95 |
| Support Level | $2.32 | $8.38 |
| Resistance Level | $3.75 | N/A |
| Average True Range (ATR) | 0.08 | 0.63 |
| MACD | 0.07 | 0.08 |
| Stochastic Oscillator | 89.69 | 93.55 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.